An mTORC1-to-CDK1 Switch Maintains Autophagy Suppression during Mitosis

Mol Cell. 2020 Jan 16;77(2):228-240.e7. doi: 10.1016/j.molcel.2019.10.016. Epub 2019 Nov 13.

Abstract

Since nuclear envelope breakdown occurs during mitosis in metazoan cells, it has been proposed that macroautophagy must be inhibited to maintain genome integrity. However, repression of macroautophagy during mitosis remains controversial and mechanistic detail limited to the suggestion that CDK1 phosphorylates VPS34. Here, we show that initiation of macroautophagy, measured by the translocation of the ULK complex to autophagic puncta, is repressed during mitosis, even when mTORC1 is inhibited. Indeed, mTORC1 is inactive during mitosis, reflecting its failure to localize to lysosomes due to CDK1-dependent RAPTOR phosphorylation. While mTORC1 normally represses autophagy via phosphorylation of ULK1, ATG13, ATG14, and TFEB, we show that the mitotic phosphorylation of these autophagy regulators, including at known repressive sites, is dependent on CDK1 but independent of mTOR. Thus, CDK1 substitutes for inhibited mTORC1 as the master regulator of macroautophagy during mitosis, uncoupling autophagy regulation from nutrient status to ensure repression of macroautophagy during mitosis.

Keywords: ATG13; ATG14; CDK1; RAPTOR; TFEB; ULK1; autophagy; mTOR; mitosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • A549 Cells
  • Autophagy / physiology*
  • CDC2 Protein Kinase / metabolism*
  • Cell Line
  • Cell Line, Tumor
  • Female
  • HCT116 Cells
  • HEK293 Cells
  • HT29 Cells
  • HeLa Cells
  • Humans
  • Lysosomes / metabolism
  • Male
  • Mechanistic Target of Rapamycin Complex 1 / metabolism*
  • Mitosis / physiology*
  • Phosphorylation / physiology
  • Signal Transduction / physiology

Substances

  • Mechanistic Target of Rapamycin Complex 1
  • CDC2 Protein Kinase
  • CDK1 protein, human